Service client ractif : notre quipe reste disponible pour rpondre aux questions, aider choisir la formule la plus adapte et, si besoin, vrifier lauthenticit des produits
Risk Factors for Cholelithiasis
Clinical evidence demonstrates that GLP-1 medications continue to provide metabolic benefits, including improved glycaemic control and, in people with type 2 diabetes, cardiovascular risk reduction, even when weight loss stabilises
These include: fatigue (low energy) dizziness injection site reactions, such as discomfort or skin discoloration small increase in heart rate changes in how things taste, such as having a bitter, metallic, or sour taste in your mouth digestive problems, such as: abdominal pain constipation or diarrhea flatulence (gas) or burping nausea and vomiting upset stomach Medical Perspective GLP-1 agonists may cause fatigue and other side effects